Litigation Details for Medicure International, Inc. v. Nexus Pharmaceuticals, Inc. (N.D. Ill. 2019)
✉ Email this page to a colleague
Medicure International, Inc. v. Nexus Pharmaceuticals, Inc. (N.D. Ill. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-12-04 |
| Court | District Court, N.D. Illinois | Date Terminated | 2020-11-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Sharon Johnson Coleman |
| Jury Demand | None | Referred To | |
| Patents | 6,770,660 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Medicure International, Inc. v. Nexus Pharmaceuticals, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Medicure International, Inc. v. Nexus Pharmaceuticals, Inc. (N.D. Ill. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-12-04 | 1 | Complaint | States Code, involving U.S. Patent No. 6,770,660 (“the ’660 patent” or “the patent in suit”), attached hereto… This is a civil action for patent infringement arising under the patent laws of the United States, … issued by the U.S. Patent and Trademark Office on August 3, 2004. The ’660 patent … to the ’660 patent. 18. Pursuant to 21 U.S.C. § 355(b)(1), the ’660 patent was submitted…expiration of the ’660 patent is itself an act of infringement of the ’660 patent. 37. Under | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
